Details of the Drug
General Information of Drug (ID: DMX1AY4)
Drug Name |
PD-168077
|
|||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
PD-168077; 190383-31-4; CHEMBL45244; PD 168077; PD-168,077; N-[[4-(2-cyanophenyl)piperazin-1-yl]methyl]-3-methylbenzamide; Benzamide, N-[[4-(2-cyanophenyl)-1-piperazinyl]methyl]-3-methyl-; PD 168,077 maleate salt; N-((4-(2-cyanophenyl)piperazin-1-yl)methyl)-3-methylbenzamide; AC1MURTZ; Tocris-1065; NCGC00015791-01; Lopac-P-233; Biomol-NT_000050; Lopac0_000969; GTPL975; BPBio1_001301; SCHEMBL4002275; DTXSID7044007; NOCAS_44007; CHEBI:94634; BCP08352; ZINC25758996; BDBM50058225; AKOS028108749; CCG-205049; NCGC00024977-02
|
|||||||||||||||||||
Indication |
|
|||||||||||||||||||
Drug Type |
Small molecular drug
|
|||||||||||||||||||
Structure | ||||||||||||||||||||
3D MOL | 2D MOL | |||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 334.4 | ||||||||||||||||||
Topological Polar Surface Area (xlogp) | 3 | |||||||||||||||||||
Rotatable Bond Count (rotbonds) | 4 | |||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 1 | |||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 4 | |||||||||||||||||||
Chemical Identifiers |
|
|||||||||||||||||||
Cross-matching ID | ||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||
References